High fidelity simulations enabled by high-performance computing will allow for unprecedented predictive power of molecular level processes that are not amenable to experimental measurement.
PNNL data scientist in the Biological Sciences Division won the 2023 JSM Data Challenge Expo. The award-winning analysis focused on the ability to identify crime patterns by correlating them with historical events and trends.
The PNNL-managed Building America Solution Center translates research into actionable considerations for homeowners and builders to provide two solutions in one: increasing energy efficiency while also enhancing disaster resistance.
This PNNL project was the focus of Nune’s talk when he delivered the keynote for the Carbon Capture and Utilization track at the 2nd Annual Baker Hughes Energy Frontiers Summit.
A PNNL team’s analysis of new-housing data concludes that single-family homes in lower-income counties are less energy-code-compliant than in higher-income counties, a finding that could shape strategies for enhanced code adoption.
The American Society of Heating, Refrigerating and Air-Conditioning Engineers has given its 2022 Journal Paper Award to Jamie Kono, a PNNL building research engineer.
PNNL’s extensive portfolio of buildings-grid research included three projects that helped answer some of the technical questions related to leveraging energy consumption in buildings to enhance grid operations.
The Northwest Connected Communities Summit brought together representatives of five Department of Energy-funded Connected Communities Projects to share ideas and discuss potential collaboration opportunities.
PNNL chemist Christopher Anderton recently named president-elect of the Imaging Mass Spectrometry Society (IMSS). In this new position, he will help lead the merge of IMSS with a European-based society, currently underway.
Bobbie-Jo Webb-Robertson is a leader with a PhD in decision sciences & engineering systems from Rensselaer Polytechnic Institute and experience in managing complex scientific programs and line organizations. She assumed the role 3/13/23.
Gosline works to develop computational algorithms that are uniquely targeted for rare disease work by doing foundational research in model system development. This work can be expanded to all model systems in human disease.
Data-driven autonomous technology to rapidly design and deliver antiviral interventions targeting SARS-CoV-2 to reduce drug discovery timeline and advance bio preparedness capabilities.